←back to thread

Goldman Sachs asks in biotech Report: Is curing patients a sustainable business? (2018)

(www.cnbc.com)
249 points randycupertino | 1 comments | 16 Nov 25 23:01 UTC | HN request time: 0.196s | source
1. unyttigfjelltol ◴[16 Nov 25 23:55 UTC] No.45949632[source]▶
The analyst is stuck in the past. Genomic solutions are personalized medicine. As long as there are new people, and new combinations of genes, there will be problems to solve.

Grow up Goldman.